ACCURAY WKN: A0MKWM ISIN: US0043971052 Kürzel: XEJ Forum: Aktien Thema: Hauptdiskussion

1,775 EUR
+0,57 %+0,010
23. Dec, 09:32:06 Uhr, Baader Bank
Kommentare 259
Summer.76
Summer.76, 19.09.2022 21:32 Uhr
1

Ich finde das man genug Informationen erhält und es stimmen auch die Zahlen. Ein gutes Unternehmen für die Zukunft

Ich bin auch nicht unzufrieden, aber Geduld wird man trotzdem noch brauchen. So ziehe ich sie nebenbei per Sparplan höher und den Rest macht das Unternehmen 😉
MrTraxxas
MrTraxxas, 19.09.2022 20:04 Uhr
0
Ich finde das man genug Informationen erhält und es stimmen auch die Zahlen. Ein gutes Unternehmen für die Zukunft
MrTraxxas
MrTraxxas, 19.09.2022 16:19 Uhr
1
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(22)00517-4/fulltext
Summer.76
Summer.76, 07.09.2022 15:37 Uhr
1
Accuray Partners with Swiss-based Genolier Innovation Hub to Bring Medical and Technological Advances to Patients Faster https://www.prnewswire.com/news-releases/accuray-partners-with-swiss-based-genolier-innovation-hub-to-bring-medical-and-technological-advances-to-patients-faster-301618994.html
MrTraxxas
MrTraxxas, 11.08.2022 16:11 Uhr
1
Na sie lebt noch
Summer.76
Summer.76, 11.08.2022 5:58 Uhr
0
Accuray rises 5% following fiscal 2022 Q4 beats, fY 2023 revenue range within consensus https://seekingalpha.com/news/3871144-accuray-rises-5-following-fiscal-2022-q4-beats-fy-2023-revenue-range-within-consensus • Accuray Inc. (NASDAQ:ARAY) is up 5% in after-hours trading after reporting fiscal 2022 Q4 results that beat on the top and bottom lines and issuing a FY 2023 revenue estimate that falls within analyst consensus. • The company projects FY 2023 revenue of $447M-$455M. The consensus estimate is $451.29M • Adjusted EBITDA is expected in the range of $26 million to $30 million. • Net loss of ~3.5M in the quarter was ~69% narrower compared to FQ4 2021. • Revenue of $110.M was a ~1% year-over-year increase. • Accuray ended the quarter with $88.7M in cash and cash equivalents, a 24% decline from the end of FQ4 2021.
Summer.76
Summer.76, 11.08.2022 5:58 Uhr
0
Accuray GAAP EPS of -$0.04 beats by $0.03, revenue of $110.02M beats by $4.7M https://seekingalpha.com/news/3870996-accuray-gaap-eps-of-0_04-beats-0_03-revenue-of-110_02m-beats-4_7m
Summer.76
Summer.76, 11.08.2022 5:57 Uhr
0
Accuray Reports Fourth Quarter and Fiscal 2022 Financial Results https://www.prnewswire.com/news-releases/accuray-reports-fourth-quarter-and-fiscal-2022-financial-results-301603116.html 8.5% FY22 revenue growth; Company issues guidance for FY23
MrTraxxas
MrTraxxas, 14.07.2022 11:31 Uhr
0
https://www.surgicalroboticstechnology.com/news/new-clinical-studies-show-benefits-of-accuray-cyberknife-in-treatment-of-neurological-indications/
MrTraxxas
MrTraxxas, 12.07.2022 17:18 Uhr
0
Sau 👍
Summer.76
Summer.76, 12.07.2022 15:49 Uhr
0
Accuray CyberKnife® System Real World Data and Clinical Studies Show Benefits in Treatment of Neurological https://www.prnewswire.com/news-releases/accuray-cyberknife-system-real-world-data-and-clinical-studies-show-benefits-in-treatment-of-neurological-indications-301583528.html
Summer.76
Summer.76, 23.06.2022 16:27 Uhr
0
https://www.benzinga.com/quote/ARAY/analyst-ratings Accuray Price Target Announced at $7.50/Share by B. Riley Securities
Summer.76
Summer.76, 02.06.2022 16:37 Uhr
1
Accuray and Limbus AI Inc. Partner to Leverage Limbus' Innovative AI-driven Technology to Enhance Accuray Adaptive Radiotherapy Solutions https://www.prnewswire.com/news-releases/accuray-and-limbus-ai-inc-partner-to-leverage-limbus-innovative-ai-driven-technology-to-enhance-accuray-adaptive-radiotherapy-solutions-301559886.html Partnership will Enable Accuray to Use Limbus' Technology to Streamline the Treatment Planning Process and Increase Operational Efficiency
Summer.76
Summer.76, 10.05.2022 16:24 Uhr
0
New Data Presented at ESTRO 2022 Reinforce Benefits of Accuray CyberKnife® and TomoTherapy® Platforms Across a Range of Indications and Complexities https://www.prnewswire.com/news-releases/new-data-presented-at-estro-2022-reinforce-benefits-of-accuray-cyberknife-and-tomotherapy-platforms-across-a-range-of-indications-and-complexities-301543379.html More Than 70 Abstracts Build on the Clinical Evidence Supporting the Use of These Technologies
Summer.76
Summer.76, 05.05.2022 15:50 Uhr
1
Accuray ClearRT™ Helical Fan-Beam kVCT Imaging Wins "Best New Technology Solution for Oncology" MedTech Breakthrough Award https://www.prnewswire.com/news-releases/accuray-clearrt-helical-fan-beam-kvct-imaging-wins-best-new-technology-solution-for-oncology-medtech-breakthrough-award-301540539.html Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies
Summer.76
Summer.76, 27.04.2022 22:17 Uhr
0
https://investors.accuray.com/news-releases/news-release-details/accuray-announces-suzanne-winter-president-promoted-president
Meistdiskutiert
Thema
1 ATOS Hauptdiskussion +2,27 %
2 VW Hauptdiskussion -2,71 %
3 Trading- und Aktien-Chat
4 MANZ Hauptdiskussion +22,54 %
5 VALNEVA SE Hauptdiskussion -0,66 %
6 MicroStrategy -0,95 %
7 DPCM Capital Hauptdiskussion +8,13 %
8 RHEINMETALL Hauptdiskussion +2,23 %
9 für alle, die es ehrlich meinen beim Traden.
10 Nio für normale Kommunikation +0,25 %
Alle Diskussionen
Aktien
Thema
1 ATOS Hauptdiskussion +2,27 %
2 VW Hauptdiskussion -2,71 %
3 MANZ Hauptdiskussion +22,54 %
4 VALNEVA SE Hauptdiskussion -0,69 %
5 MicroStrategy -1,55 %
6 DPCM Capital Hauptdiskussion +8,13 %
7 RHEINMETALL Hauptdiskussion +2,06 %
8 Nio für normale Kommunikation +0,25 %
9 Aethlon Medical, Inc. +3,76 %
10 PLUG POWER Hauptdiskussion +0,85 %
Alle Diskussionen